{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:48:31Z","timestamp":1777639711985,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070588"],"award-info":[{"award-number":["82070588"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022419","name":"National Institute for Health Research Southampton Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-20004"],"award-info":[{"award-number":["IS-BRC-20004"]}],"id":[{"id":"10.13039\/501100022419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.iliver.2022.02.001","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T06:37:37Z","timestamp":1646894257000},"page":"30-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?"],"prefix":"10.1016","volume":"1","author":[{"given":"Feng","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth I.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael S.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ou-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iliver.2022.02.001_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.001_bib2","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"58","author":"Stepanova","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.001_bib3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.31806","article-title":"Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease","volume":"74","author":"Alexopoulos","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.iliver.2022.02.001_bib4","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.numecd.2021.02.018","article-title":"The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"31","author":"Sun","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.001_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MEG.0000000000001746","article-title":"Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease","volume":"33","author":"Zhu","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.001_bib6","first-page":"107","article-title":"PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels","volume":"40","author":"Sun","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"9","key":"10.1016\/j.iliver.2022.02.001_bib7","first-page":"2160","article-title":"Metabolic-associated fatty liver disease is associated with severity of COVID-19","volume":"40","author":"Zhou","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"4","key":"10.1016\/j.iliver.2022.02.001_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2020.12.016","article-title":"Clinical utility of the MAFLD definition","volume":"74","author":"Zheng","year":"2021","journal-title":"J\u00a0\u200bHepatol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.001_bib9","first-page":"412","article-title":"External validation of the nonalcoholic steatohepatitis scoring system in patients with biopsy-proven nonalcoholic fatty liver disease in China","volume":"19","author":"Xu","year":"2021","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.001_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.numecd.2020.10.004","article-title":"Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD","volume":"31","author":"Zhou","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.iliver.2022.02.001_bib11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.iliver.2022.02.001_bib12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/2050640619868352","article-title":"Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram","volume":"7","author":"Zhou","year":"2019","journal-title":"United Euro Gastroenterol J"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.001_bib13","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1111\/jgh.15554","article-title":"TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"36","author":"Ma","year":"2021","journal-title":"J.\u00a0\u200bGastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.iliver.2022.02.001_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12944-018-0920-4","article-title":"AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study","volume":"17","author":"Liu","year":"2018","journal-title":"Lipids Health Dis"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.001_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111173","article-title":"Fluctuation between fasting and 2-H postload glucose state is associated with glomerular hyperfiltration in newly diagnosed diabetes patients with HbA1c < 7%","volume":"9","author":"Hou","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.001_bib16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/ije\/dyaa103","article-title":"The role of overweight in the association between the Mediterranean diet and the risk of type 2 diabetes mellitus: a mediation analysis among 21 585 UK biobank participants","volume":"49","author":"Andr\u00e9","year":"2020","journal-title":"Int. J Epidemiol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.001_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","article-title":"Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C","volume":"26","author":"Tanwar","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.iliver.2022.02.001_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/1471-2164-14-625","article-title":"Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotype","volume":"14","author":"Onate","year":"2013","journal-title":"BMC Genom"},{"issue":"14","key":"10.1016\/j.iliver.2022.02.001_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121221","article-title":"Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin","volume":"3","author":"Arora","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.iliver.2022.02.001_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-230X-13-3","article-title":"Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population","volume":"13","author":"Ma","year":"2013","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"10.1016\/j.iliver.2022.02.001_bib21","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/ajg.2010.275","article-title":"Impact of nonalcoholic fatty liver disease on insulin\u00a0resistance in relation to HbA1c levels in nondiabetic subjects","volume":"105","author":"Bae","year":"2010","journal-title":"Am J Gastroenterol"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947822000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947822000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:31:16Z","timestamp":1762648276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947822000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2772947822000020"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2022.02.001","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2022.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}]}}